Claris Lifesciences Ltd IPO : Broker’s Recomendations

by khalid on 19/12/2010 · 0 comments

Claris Lifesciences Ltd is entering into primary market with an Initial Public Offer (IPO) of 8848921 Equity Shares of Rs 10 each. The IPO is opening on 24th Nov 2010 and the shares will be available for subscription up to 2nd Dec 2010 after extension of date, earlier it was 26th Nov 2010. The premium of the issue will be decided through a 100% Book Building Process. The price band for the issue has been fixed as Rs 278-293/share. But now it has been revised to Rs 228-235/share. Fitch has assigned 3 out of 5 grade. So its an ‘Average Fundamentals’ and that is positive sign. Claris Lifesciences is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. The company’s products range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral & parenteral nutrition and oncology. The customer base primarily includes government and private hospitals, aid agencies, and nursing homes.

Most of the broker’s houses have recommend to subscribe the IPO. There views are given below :-

Angel Broking : Subscribe

Nirmal Bang : Positive

KR Choksey : Subscribe

MLR Securities : Subscribe

Anagram : Subscribe

SMC : Rreasonable

SP Tulsian : Avoid

Stay tuned to BelltheBull Blog for more news on Claris Lifesciences Ltd IPO !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: